The research article corresponding to this dataset is Abbara et al, Drug-induced liver injury from antituberculous treatment: a retrospective study from a large TB centre in the UK, BMC Infectious Diseases, 2017.

This dataset provides sufficient data to replicate the findings reported in Table 2 (Characteristics of pDILI Type 1 cases (BTS/ATS criteria) and controls) and Table 3 (Odds ratios for exposures among pDILI Type 1 cases compared with
controls).

id			Unique anonymous patient ID
pdili			Possible DILI cases (0=no, 1=yes)
t1dili			Type 1 DILI cases (0=no, 1=yes)
agegroup		Age (years)
sex			Sex (M/F)
weight			KG
rifam_dpw		Rifampicin dose per weight (mg/kg)
ison_dpw		Isoniazid dose per weight (mg/kg)
pyraz_dpw		Pyrazinamide dose per weight (mg/kg)
moxi_dpw		Moxifloxacin dose per weight (mg/kg)
hiv			HIV positive (0=no, 1=yes)
hcv			HCV positive (0=no, 1=yes)
hbv			HBV positive (0=no, 1=yes)
alcohol			Alcohol consumption (0=nil, 1=any)
liver_disease		Liver disease (0=n, 1=yes)
tb_site			Site of TB (1=pulmonary, 2=extrapulmonary, 3=both)
time_to_onset_of_pDILI	Time to onset of possible DILI
log10base_alt		Log 10 transformed baseline ALT
log10base_alp		Log 10 transformed baseline ALP
log10base_bili		Log 10 transformed baseline bilirubin
